Scleroderma treated with 2% procaine intravenously.
D001487:Basidiomycota; D006801:Humans; D011343:Procaine / Q000627:therapeutic use*; D012594:Scleroderma, Localized; D012595:Scleroderma, Systemic / Q000628:therapy*
D011343:Procaine
PROCAINE/therapeutic use; SCLERODERMA/therapy